Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Drexler

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Circulation Research|January 8, 2005
Bone marrow stem cells for myocardial infarction: effector or mediator?Florian P Limbourg, Helmut Drexler
Nature Reviews. Cardiology|September 24, 2009
Stem cells: bone marrow cell therapy for MI-goal achieved?Helmut Drexler, Kai C Wollert
Nature Reviews. Cardiology|February 24, 2010
Cell therapy for the treatment of coronary heart disease: a critical appraisalKai C Wollert, Helmut Drexler
Circulation|October 23, 2002
Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?Kai C Wollert, Helmut Drexler
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Cell therapy for acute myocardial infarction: where are we heading?Kai C Wollert, Helmut Drexler
Nature Clinical Practice. Cardiovascular Medicine|May 21, 2008
What are the clinical effects of bone marrow cell therapy in patients with severe coronary artery disease?L Christian Napp, Helmut Drexler
Current Opinion in Cardiology|April 8, 2006
Cell-based therapy for heart failureKai C Wollert, Helmut Drexler
European Heart Journal|December 9, 2003
Growth hormone and proinflammatory cytokine activation in heart failure. Just a new verse to an old sirens' song?Kai C Wollert, Helmut Drexler
Journal of Molecular and Cellular Cardiology|October 24, 2002
ACE inhibition improves cardiac force generation after myocardial infarctionDenise Hilfiker-Kleiner, Helmut Drexler
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
Reassessing guidelines for heart failureHelmut Drexler, Kai C Wollert
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Circulation Research|January 8, 2005
Bone marrow stem cells for myocardial infarction: effector or mediator?Florian P Limbourg, Helmut Drexler
Nature Reviews. Cardiology|September 24, 2009
Stem cells: bone marrow cell therapy for MI-goal achieved?Helmut Drexler, Kai C Wollert
Nature Reviews. Cardiology|February 24, 2010
Cell therapy for the treatment of coronary heart disease: a critical appraisalKai C Wollert, Helmut Drexler
Circulation|October 23, 2002
Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?Kai C Wollert, Helmut Drexler
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Cell therapy for acute myocardial infarction: where are we heading?Kai C Wollert, Helmut Drexler
Nature Clinical Practice. Cardiovascular Medicine|May 21, 2008
What are the clinical effects of bone marrow cell therapy in patients with severe coronary artery disease?L Christian Napp, Helmut Drexler
Current Opinion in Cardiology|April 8, 2006
Cell-based therapy for heart failureKai C Wollert, Helmut Drexler
European Heart Journal|December 9, 2003
Growth hormone and proinflammatory cytokine activation in heart failure. Just a new verse to an old sirens' song?Kai C Wollert, Helmut Drexler
Journal of Molecular and Cellular Cardiology|October 24, 2002
ACE inhibition improves cardiac force generation after myocardial infarctionDenise Hilfiker-Kleiner, Helmut Drexler
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
Reassessing guidelines for heart failureHelmut Drexler, Kai C Wollert
Pageof 19